Background: Patients with hematologic malignancies (HM) often receive aggressive care at
the end of life (EOL). Early palliative care (PC) has been shown to improve EOL care …

Background: Patients with hematologic malignancies often receive aggressive care at the
end of life (EOL), leading to lower quality of life. Access to early palliative care may improve …

Background: Patients with hematologic malignancies (HMs) receive more disease directed
care at the end of life (EOL) and often die in the hospital. The impact of early palliative care …

Patients with hematologic malignancies are thought to receive more aggressive end-of-life
(EOL) care and have suboptimal hospice use compared with patients with solid tumors, but …

Association between palliative care and end-of-Life care for... : Medicine Association between
palliative care and end-of-Life care for patients with hematological malignancies: A …

Background: Early palliative care is increasingly used in solid organ malignancy but is less
established in patients with hematologic malignancy. Disease-related factors increase the …

Purpose Little is known about the patterns and predictors of the use of end-of-life health care
among patients with acute myeloid leukemia (AML). End-of-life care is particularly relevant …

PURPOSE: Palliative care (PC) plays an established role in improving outcomes in patients
with solid tumors, yet these services are underutilized in hematologic malignancies (HMs) …

Palliative care has been defined as specialized care for patients facing serious illnesses.
Despite advancements in the field and studies documenting the effectiveness of early …

Evidence points to many benefits of “early palliative care,” the provision of specialist
palliative care services upstream from the end of life, to improve patients' quality of life while …